Marker Therapeutics (MRKR) Prepaid Assets (2010 - 2026)
Marker Therapeutics (MRKR) reported Prepaid Assets of $13203.0 for Q1 2026, down 98.43% year-over-year from $841293.0 in Q1 2025, and down 98.0% quarter-over-quarter from $658750.0 in Q4 2025.
Marker Therapeutics (MRKR) Prepaid Assets (2010 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has 16 years of Prepaid Assets data on file, last reported at $13203.0 in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $13203.0, down 98.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $13203.0 (down 98.43% YoY), and the FY2025 annual result was $658750.0, up 32837.5% from the prior year.
- Prepaid Assets slipped to $13203.0 in Q1 2026 per MRKR's latest filing, from $658750.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.8 million in Q2 2022 and troughed at $2000.0 in Q4 2024.
- A 5-year average of $1.5 million and a median of $1.4 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 99.8% in 2024, then soared 32837.5% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $1.8 million in 2022, then slumped by 46.57% to $988126.0 in 2023, then slumped by 99.8% to $2000.0 in 2024, then soared by 32837.5% to $658750.0 in 2025, then sank by 98.0% to $13203.0 in 2026.
- Business Quant data shows MRKR's Prepaid Assets at $13203.0 in Q1 2026, $658750.0 in Q4 2025, and $841293.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Marker Therapeutics | 27.04 Mn | 27.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,203.00 |
| Dec 31, 2025 | 658,750.00 |
| Mar 31, 2025 | 841,293.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 917,009.00 |
| Dec 31, 2023 | 988,126.00 |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 2.67 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 2.20 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.70 Mn |
| Jun 30, 2021 | 2.80 Mn |
| Mar 31, 2021 | 1.96 Mn |
| Dec 31, 2020 | 2.06 Mn |